All Stories

  1. Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management
  2. Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature
  3. The Biology of Veganism: Plasma Metabolomics Analysis Reveals Distinct Profiles of Vegans and Non-Vegetarians in the Adventist Health Study-2 Cohort
  4. ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
  5. Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
  6. PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6
  7. Methylomes in Vegans versus Pescatarians and Nonvegetarians
  8. Oxidative stress markers in patient-derived non-cancerous cervical tissues and cells
  9. The Potential of Immune Checkpoint Blockade in Cervical Cancer: Can Combinatorial Regimens Maximize Response? A Review of the Literature
  10. Effects of Lifestyle Factors on Cognitive Resilience: Commentary on “What This Sunny, Religious Town in California Teaches Us About Living Longer”
  11. Cold parenting is associated with cellular aging in offspring: A retrospective study
  12. Cancer stem cell self-renewal as a therapeutic target in human oral cancer
  13. Oxidative stress in clinical samples
  14. Subpopulations of cancer stem cells found in papillary thyroid carcinoma
  15. Association between markers of glucose metabolism and risk of colorectal cancer
  16. Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV+ cells
  17. Combined ultrasound-curcumin treatment of human cervical cancer cells
  18. Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer
  19. Abstract 1828: Proteomic analysis of the effect of E6 star expression on cellular pathways in HPV positive SiHa and HPV negative C33A cervical carcinoma cells
  20. Selenium Attenuates HPV-18 Associated Apoptosis in Embryo-Derived Trophoblastic Cells but Not Inner Cell Mass In Vitro
  21. Long-term, Aerobic Training Increases Adiponectin Levels in Trained, Middle-aged Females more than in Comparable Males
  22. Viral Carcinogenesis: Factors Inducing DNA Damage and Virus Integration
  23. Abstract 3175: The splice variant of the human papillomavirus 16 E6 protein, E6*, displays anti-tumor propertiesin vivo
  24. Linifanib (ABT-869), enhances cytotoxicity with poly (ADP-ribose) polymerase inhibitor, veliparib (ABT-888), in head and neck carcinoma cells
  25. Paraspeckle Protein 1 (PSPC1) Is Involved in the Cisplatin Induced DNA Damage Response—Role in G1/S Checkpoint
  26. Human Papillomavirus Type 16 E6* Induces Oxidative Stress and DNA Damage
  27. A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages
  28. The small splice variant of HPV16 E6, E6⁎, reduces tumor formation in cervical carcinoma xenografts
  29. Proteomic Analysis of Cellular Response Induced by Multi-Walled Carbon Nanotubes Exposure in A549 Cells
  30. Cellular Levels of Oxidative Stress Affect the Response of Cervical Cancer Cells to Chemotherapeutic Agents
  31. Modern Molecular and Clinical Approaches to Eradicate HPVMediated Cervical Cancer
  32. Quantum dot-related genotoxicity perturbation can be attenuated by PEG encapsulation
  33. Modulation of Apoptotic Pathways by Human Papillomaviruses (HPV): Mechanisms and Implications for Therapy
  34. Interleukin 24: Mechanisms and therapeutic potential of an anti-cancer gene
  35. Methyl methanesulfonate induces apoptosis in p53-deficient H1299 and Hep3B cells through a caspase 2- and mitochondria-associated pathway
  36. Cisplatin treatment leads to changes in nuclear protein and microRNA expression
  37. DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells
  38. Increased Ceramide in Brains with Alzheimer's and Other Neurodegenerative Diseases
  39. Small molecule inhibitors of the HPV16-E6 interaction with caspase 8
  40. Nuclear proteome analysis of benzo(a)pyrene-treated HeLa cells
  41. Splice variants of mda-7/IL-24 differentially affect survival and induce apoptosis in U2OS cells
  42. Mass Spectrometric Studies on Epigenetic Interaction Networks in Cell Differentiation
  43. Benzo[a]pyrene induces complex H2AX phosphorylation patterns by multiple kinases including ATM, ATR, and DNA-PK
  44. Long-term, progressive, aerobic training increases adiponectin in middle-aged, overweight, untrained males and females
  45. Quantification of ceramide levels in mammalian cells by high performance liquid chromatography coupled to tandem mass spectrometry with multiple-reaction-monitoring mode (HPLC-MS/MS-MRM)
  46. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress
  47. Nuclear proteome analysis of cisplatin-treated HeLa cells
  48. Benzo[a]pyrene treatment leads to changes in nuclear protein expression and alternative splicing
  49. The Full-Length Isoform of Human Papillomavirus 16 E6 and Its Splice Variant E6* Bind to Different Sites on the Procaspase 8 Death Effector Domain
  50. Complexes of Human Papillomavirus Type 16 E6 Proteins Form Pseudo-Death-Inducing Signaling Complex Structures during Tumor Necrosis Factor-Mediated Apoptosis
  51. Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes
  52. The Interaction between Human Papillomavirus Type 16 and FADD Is Mediated by a Novel E6 Binding Domain
  53. C18 ceramide analysis in mammalian cells employing reversed-phase high-performance liquid chromatography tandem mass spectrometry
  54. Cellular binding partners of the human papillomavirus E6 protein
  55. The Early Response to DNA Damage Can Lead to Activation of Alternative Splicing Activity Resulting in CD44 Splice Pattern Changes
  56. Bid is cleaved upstream of caspase-8 activation during TRAIL-mediated apoptosis in human osteosarcoma cells
  57. The Large and Small Isoforms of Human Papillomavirus Type 16 E6 Bind to and Differentially Affect Procaspase 8 Stability and Activity
  58. Modulation of apoptosis by human papillomavirus (HPV) oncoproteins
  59. Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis
  60. The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose
  61. The Human Papillomavirus 16 E6 Protein Binds to Fas-associated Death Domain and Protects Cells from Fas-triggered Apoptosis
  62. Ceramide and Other Sphingolipids in Cellular Responses
  63. ATM and ATR: Sensing DNA damage
  64. ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses
  65. Inorganic and Dimethylated Arsenic Species Induce Cellular p53
  66. Protein kinases and their involvement in the cellular responses to genotoxic stress
  67. The Human Papillomavirus 16 E6 Protein Binds to Tumor Necrosis Factor (TNF) R1 and Protects Cells from TNF-induced Apoptosis
  68. Activation of a p53-independent, Sphingolipid-mediated Cytolytic Pathway in p53-negative Mouse Fibroblast Cells Treated with N-Methyl-N-nitro-N-nitrosoguanidine
  69. HPV 16 E6 Blocks TNF-Mediated Apoptosis in Mouse Fibroblast LM Cells
  70. p53 Induction as a Genotoxic Test for Twenty-Five Chemicals Undergoing in Vivo Carcinogenicity Testing
  71. p53 induction as a genotoxic test for twenty-five chemicals undergoing in vivo carcinogenicity testing
  72. A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage
  73. Macrophage-Mediated Cytotoxicity
  74. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor.
  75. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase
  76. Affinity chromatography using protein immobilized via arginine residues: purification of ubiquitin carboxyl-terminal hydrolases
  77. Structure and function of ubiquitin: evidence for differential interactions of arginine-74 with the activating enzyme and the proteases of ATP-dependent proteolysis
  78. Immobilization of proteins via arginine residues
  79. Measurement of Macrophage-Mediated Cytolysis of Adenovirus-Infected Cells